Monthly Archives: March 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against IRSA Inversiones y Representaciones S.A. (IRSA) and Lead Plaintiff Deadline: April 25, 2016

NEW YORK , NY / ACCESSWIRE / March 29, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against IRSA Inversiones y Representaciones S.A. (“IRSA” or the “Company”) (NYSE: IRS). The class action has been filed in the USDC for the Central District of California on behalf of a class consisting of all persons or entities who purchased IRSA Inversiones y Representaciones S.A. American Depositary Receipts during the period between November 3, 2014 and December 30, 2015 inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The complaint alleges that throughout the Class Period, the Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) IRSA’s subsidiary, Dolphin Netherlands B.V. (“Dolphin”), does not sufficiently qualify as a Venture Capital Organization, and therefore, IDB Development Corporation Limited’s (“IDBD”) $6.7 billion net debt should be consolidated with IRSA’s financial statements; (2) the upcoming consolidation of IDBD’s debt would violate IRSA’s Global Notes Indenture; (3) the terms of the February 10, 2015 related party transaction between Dolphin and Inversiones Financieras Del Sur S.A.; and (4) as a result, IRSA’s public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint and join the action, visit the firm’s website: http://www.bgandg.com/#!irsa/cfa3t. To discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in IRSA Inversiones y Representaciones S.A. you have until April 25, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 437399

CGrowth Capital Provides Update and Confirms Funding on Corporate Bond

SILVERDALE, WA / ACCESSWIRE / March 29, 2016 / CGrowth Capital, Inc. (OTC Pink: CGRA) (the “Company”) is pleased to announce that its wholly owned subsidiary CGrowth Capital Bond, Ltd. has received initial subscriptions of its £15,000,000.00 British Pounds Sterling (“GBP”) bond offering in the amount of £7,300,000.00 GBP. The Company’s subsidiary has successfully completed and received the subscriptions and is working towards fulfillment of the remainder of the bond offering.

The bonds subscribed include £4,100,000.00 GBP in cash (or ~$ 5,700,000.00 USD gross proceeds), a note receivable in the amount of £1,900,000.00 GBP, and equity in the amount of £1,300,000.00 GBP. Funding from the bond subscriptions are being used to finance the three (3) bond projects, including the Company’s Powder River basin oil and gas project in Wyoming.

“We are elated to make this announcement!” stated Bill Wright, CEO of CGrowth Capital, Inc. “This is an important milestone and we are not looking back.”

The Company’s subsidiary, Powder River Resources, Inc.’s proven and probable oil reserves, which management estimates to be $250,000,000.00, is the focus of the funding. Powder River Resources, Inc. and CGrowth Capital Bond Ltd. have an umbrella policy of $10,000,000.00 covering the project.

For more information about CGrowth Capital Bond Ltd. visit: http://CGrowthCapitalBond.com.

About CGrowth Capital, Inc.:

CGrowth Capital, Inc. The Company continues to serve as an alternative asset management company for businesses and assets focused on all aspects of mining, minerals, exploration, and commercial real estate. The processing of metal ore mining, mineral and specialty rock extraction, as well as oil and gas production, are multi-billion dollar market opportunities which is capitalized on through processing, sales, contracting and licensing of assets. CGrowth Capital’s services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold, silver, oil and gas, and dolomite to market. CGrowth Capital will focus on acquiring land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of operations.

For more information and updates about CGrowth Capital, visit their website or Facebook page:

http://www.CGrowthCapital.com
https://www.facebook.com/CGrowthCapital

Investor Inquiries:

CGrowth Capital, Inc.
888-218-2472

Safe Harbor

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. The Company disclaims any obligation to update or revise any forward-looking statements.

SOURCE: CGrowth Capital, Inc.

ReleaseID: 438238

Global Radiation Therapy Market Report 2016 Edition Now Available at MarketReportsOnline.com

MarketReportsOnline.com adds “Global Radiation Therapy Market Report: 2016 Edition” report to its research store.

Global Radiation Therapy Market Report 2016 Edition Now Available at MarketReportsOnline.com

Pune, India – March 29, 2016 /MarketersMedia/

Proton treatment industry is predominantly focused in the Americas; particularly in the North America. In the recent couple of years, it has been watched that the innovation is currently being received at a quick pace by authorities of the European and Asian economies. The innovation around proton treatment has additionally made advances in different corners of the world all on account of the growing incomes and enthusiasm of governments in its headway.

The Global Radiation Therapy Market Report: 2016 Edition research of 53 pages with 5 Tables and 47 Charts to the pharmaceuticals industry segment of its online data and intelligence library. Purchase a copy of this research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=462020.

Radiation depicts the way energy moves from one place to another. One of the top advancements in the field of radiotherapy has been the development of proton treatment as well development of linear accelerators. Proton treatment, likewise called proton beam treatment, is a kind of radiation treatment that uses protons instead of x-beams to treat disease. It is a very precise strategy for radiotherapy which is suitable for all patients irrespective of their age, mostly relying upon conclusion. A linear accelerator (LINAC) customizes high energy x-rays to conform to a tumor’s shape and destroy cancer cells while sparing surrounding normal tissue.

A number of factors driving the development of radiation treatment are expanding number of cancer cases around the world, developing inclination for non-invasive methods and mechanical advancements. Different variables like maturing population additionally advance the utilization of proton treatment. Key trending innovations like pencil bar scanning hold the possibility to hoist the capacity to treat the very intricate tumors, while leaving solid tissue and basic structures untouched.

Complete report available at http://www.marketreportsonline.com/462020.html.

This report assesses the global radiation therapy market alongwith major regional markets. The top companies having a vicious competition with each other and dominating the industry are- Varian Medical, Elekta, and Accuray Inc. These players are being profiled in the report alongside their key financials and business strategies.

Major Points from Table of Contents Provided in Radiation Therapy Market:

1. Radiation Therapy Market
1.1 Overview
1.2 Classification
1.2.1 External Beam Radiation Therapy
1.2.2 Internal Radiation Therapy or Brachytherapy
1.2.3 Other Treatment Options
1.3 Global Market Analysis
1.3.1 Global Radiation Therapy Equipment Market by Value
1.3.2 Global Radiation Therapy Equipment Market Value by Region
1.3.3 Global Radiation Therapy – Capacity Gaps
1.3.4 Global Radiation Therapy Market by Patients Treated
1.4 Regional Market Analysis
1.4.1 North America Radiation Therapy Market by Value
1.4.2 EMEA Radiation Therapy Market by Value
1.4.3 APAC Radiation Therapy Market by Value
1.4.4 Latin America Radiation Therapy Market by Value

2. Linear Accelerators
2.1 Overview
2.2 Linear Accelerators Market by Value
2.3 Linear Accelerator Volume by Region

3. Proton Therapy Market
3.1 Global Market
3.1.1 Proton Therapy Market Value
3.1.2 Proton Therapy Market Segments
3.1.3 Proton Therapy Patient Volume
3.1.4 Proton Rooms
3.1.5 Proton Therapy Cost
3.1.6 Proton Therapy Centers
3.1.7 Clinical Studies & Publications
3.2 Regional Markets
3.2.1 Patient Volume – North America
3.2.2 Patient Volume – Europe
3.2.3 Patient Volume – Asia
3.2.4 Proton Rooms – North America
3.2.5 Proton Rooms – Europe
3.2.6 Proton Rooms – Asia

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Cancer Incidences
4.1.2 Preference for Noninvasive Procedures
4.1.3 Rising Ageing Population
4.1.4 Technological Innovations
4.2 Challenges
4.2.1 High Installation Cost
4.2.2 Shortages in Low Middle Income Countries (LMIC)
4.2.3 Cost Pressures for Prostate Cancers
4.2.4 Reimbursement Rates
4.2.5 Stringent Regulations
4.3 Key Trends
4.3.1. Technological Innovation
4.3.2. Pencil Beam Scanning

5. Competitive Landscape
5.1 Product Comparison
5.1.1 On Basis of Features
5.1.2 On Basis of Price Metrics
5.2 Market Share
5.2.1 Linac Market Share
5.2.2 Proton Centre & Room Sales Market Share

6. Company Profiles
6.1 Varian Medical Systems Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Elekta
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Accuray Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

For more information about us, please visit http://www.marketreportsonline.com/contacts/purchase.php?name=462020

Contact Info:
Name: Ritesh Tiwari
Organization: Market Reports Online
Phone: + 1 888 391 5441

Source: http://marketersmedia.com/global-radiation-therapy-market-report-2016-edition-now-available-at-marketreportsonline-com/108622

Release ID: 108622

FulHum Fashion Show at BMW Charity Event

DALLAS, TX / ACCESSWIRE / March 29, 2016 / EarthWater www.EarthWater.com a manufacturer of high alkaline mineral infused beverages under the brand “FulHum” www.FulHum.com is pleased to announce its sponsorship of the KVIL Runway 1037FM Fashion Show sponsored by BMW Motor Cars http://kvil.cbslocal.com/kvil-runway-1037/ featuring Musical Artist DAUGHTRY performing LIVE http://www.daughtryofficial.com/ and Special Guest Erika Jayne from Housewives of Beverly Hills https://www.instagram.com/theprettymess/?hl=en.

The VIP exclusive event is set for Thursday March 31st from 6pm – 10pm at the Classic BMW Dealership located in Plano TX. Come mingle with Actors, Celebrities, Models and a special VIP list.

EarthWater Chairman CJ Comu, stated “This will be a spectacular evening featuring some of the hottest new stars in the Fashion Industry and Celebrities toasting the hottest new beverage brand of FulHum.”

To purchase limited number of tickets to this hot VIP Event – go to: https://www.eventbrite.com/e/kvil-runway-1037-tickets-21021312311.

FulHum’s amazing 100% natural mineral infused +9ph Alkaline beverage has 0 Calories, 0 Sugar, 0 Chemicals, 0 Additives. It is Gluten Free and Kosher. FulHum is a Fulvic & Humic compound mineral enriched beverage for natural hydration and recovery.

FulHum stands for “Fulvic and Humic” compounds, the main natural components of their 100% natural, +9pH Alkaline mineral-enriched bottled water. FulHum’s proprietary formula is different from other mineral waters because it; detoxifies free radicals, eliminates harmful pathogens, and improves nutrient absorption all while delivering essential minerals that are hard to come by in our daily diets. “Why drink ordinary water when you can now drink extraordinary FulHum”.

About EarthWater & FulHum

FulHum is a product of EarthWater www.EarthWater.com. FulHum is a Mineral Infused +9ph Alkaline Beverage which is 100% natural, proprietary blend of Fulvic and Humic complexes mined from deep within the earth’s surface. More info visit FulHum www.fulhum.com.

SOURCE: Earthwater, Inc.

ReleaseID: 438150

Local NJ Epoxy Flooring Contractors Are Going National

Local New Jersey epoxy flooring contractors, HIgh Performance Systems Corporation, are expanding their service territory on a national level. As a leader in the protective flooring industry since 1988, High Performance Systems shows no signs of slowing.

Local NJ Epoxy Flooring Contractors Are Going National

Middlesex, United States – March 29, 2016 /PressCable/

Local New Jersey epoxy flooring contractors, HIgh Performance Systems Corporation, are expanding their service territory on a national level. As a leader in the protective flooring industry since 1988, High Performance Systems show no signs of slowing. This family owned and operated business is run by father and son, Jeffrey Smedley and Stephen Smedley respectively. According to Jeffrey Smedley, “The company was built on the integrity and care that my father instilled in me and that I instill in my son. Since 1988 our mission has been to bring the latest and best technology in the field of protective surfaces to our clients and help them create a solution that meets their facility’s needs.”

Jeffrey attributes much of the company’s success to what he calls the High Performance Systems “turnkey” approach. “Some of the many facets of our service include repairing concrete, pitching of the existing substrate and the installation of trench drain systems, in addition to the custom design and installation of various resinous flooring systems. Our focus at High Performance Systems is to understand our clients’ needs and to design the appropriate protective solution to fit their schedule, conditions, and budget.”

High Performance Systems has recently completed installations in Maryland, Virginia, Massachusetts, North Carolina, and as far west as Washington State. They install epoxy flooring and other types of resinous flooring for all types of industries but have seemingly found a niche in the food processing and manufacturing industry. The company has become one of the largest installers of urethane cement flooring systems (the Cadillac of floors for the food industry) in the country, providing their services to some of the biggest names in the industry such as Smithfield Foods, Nestle and Dunkin Donuts to name a few. Director of Operations, Stephen Smedley, stated that “Over half of our work is done for food related companies, we are sought out by food processing, manufacturing, and packaging facilities as well as commercial kitchens, commercial bakeries, and restaurant kitchens not only because of our installation expertise but also because our ability to get jobs done on time. Some of our clients shut down their production lines and businesses at a huge cost and if we don’t complete their installation on time they stand to lose a lot of money. This is one of the biggest reasons for our growth”

To find out more about this growing epoxy flooring company, visit their website at http://www.highperformancesystems.com

For more information about us, please visit http://www.highperformancesystems.com

Contact Info:
Name: Jeff Smedley
Organization: High Performance Systems, Corp.
Address: 436 Lincoln Blvd. Middlesex, NJ 08846
Phone: 800 928 7220

Release ID: 108651

CFN Media Launches Ad Campaign for MyDx

SEATTLE, WA / ACCESSWIRE / March 29, 2016 / CFN Media Group, the leading creative agency and media network dedicated to legal cannabis today announced the launch of an ad campaign on behalf of MyDx Inc. (OTCQB: MYDX) to market its CannaDx handheld chemical analyzer directly to cannabis consumers.

“MyDx has developed groundbreaking product technology for the burgeoning cannabis industry,” said CFN Media President Frank Lane. “With so many variants of stains available to consumers, the personal handheld analyzer with smartphone app interface identifies how specific strains are likely to affect an individual user.”

CFN Media has released a commercial advertisement of the MyDx product that is playing across its network and media site www.cannabisfn.com and reaching an extensive audience of cannabis consumers across America.

“We are excited to be working with CFN Media to elevate our brand and drive sales in the MyDx Analyzer with CannaDx Sensor,” said Daniel Yazbeck, CEO of MyDx Inc. “With CFN’s creative production and significant industry reach across multiple digital channels, we’re poised to accelerate product sales and help the MyDx become a household name among cannabis users across the country.”

View the 30-second commercial spot here: http://www.cannabisfn.com/cfnvideo/?id=l2iU4oOd.

For more information about CFN Media’s ad campaigns, please contact Frank Lane at (206) 369-7050 or visit http://www.cannabisfn.com/marijuana-brands/.

About MyDx, Inc.

MyDx, Inc. (MYDX) is a science and technology company based in San Diego, California whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has developed MyDx, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx Analyzer and App. For more information, please visit www.cdxlife.com.

About CFN Media Group

CFN Media (CannabisFN), the leading creative agency and media network dedicated to legal cannabis, helps marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the leading brands in the space.

Frank Lane
President
CFN Media
(206) 369-7050
flane@cannabisfn.com

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Important factors that could cause these differences include, but are not limited to, the demand for the company’s services, governmental regulation of the cannabis industry, and the company’s ability to execute its business plan. Emerging Growth LLC dba TDM Financial, which owns CFN Media, is not registered with any financial or securities regulatory authority, and does not provide nor claim to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CFN Media, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit:http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: CFN Media

ReleaseID: 438241

Pipeline of Peripheral Neuropathy Market H1 2016 Covering 15 Companies

RnRMarketResearch adds Peripheral Neuropathy Market research to its database.

Pipeline of Peripheral Neuropathy Market H1 2016 Covering 15 Companies

Pune, India – March 29, 2016 /MarketersMedia/

Companies Involved in Therapeutics Development are Araim Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, aTyr Pharma, Inc., Baxalta Incorporated, CSL Limited, GeNeuro SA, INSYS Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation, Neuren Pharmaceuticals Limited, Neurocentrx Pharma Ltd., Pfizer Inc., Polyneuron Pharmaceuticals AG, RegeneRx Biopharmaceuticals, Inc., Sanofi and Teijin Pharma Limited.

The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and features dormant and discontinued projects.

Inquire more about this research at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=516253 .

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Peripheral Neuropathy (Sensory Neuropathy)
• The report reviews pipeline therapeutics for Peripheral Neuropathy (Sensory Neuropathy) by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Peripheral Neuropathy (Sensory Neuropathy) therapeutics and enlists all their major and minor projects
• The report assesses Peripheral Neuropathy (Sensory Neuropathy) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Peripheral Neuropathy (Sensory Neuropathy)

Complete research report of 100 pages with TOC is available at http://www.rnrmarketresearch.com/peripheral-neuropathy-sensory-neuropathy-pipeline-review-h1-2016-market-report.html .

For more information about us, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/pipeline-of-peripheral-neuropathy-market-h1-2016-covering-15-companies/108575

Release ID: 108575

Integrated Energy Solutions, Inc. Changes Name to Patten Energy Solutions Group, Inc.

Integrated Energy Solutions, Inc. Changes Name to Patten Energy Solutions Group, Inc and Is Now Current on OTC Markets; http://www.otcmarkets.com/stock/IENG/filings

DOLTON, IL / ACCESSWIRE / March 29, 2016 / Integrated Energy Solutions, Inc. (OTC Markets:IENG) (the “Company” or “Patten Energy” or “IES”) (www.Integrated-Energy.co), is a fully integrated large and small format downstream oil marketer as well as waste oil collector, value-adding recycler and re-distributor, announces that it has filed with the State of Nevada to amend its corporate name to Patten Energy Solutions Group, Inc.

The Company filed a Certificate of Amendment with the Secretary of State of Nevada to amend its corporate name to be Patten Energy Solutions Group, Inc., in order to better reflect the operations of the Company. The Company will be applying with FINRA for a new symbol, and when completed the information will be released.

The Company is also announcing that Robert Rosinski has been appointed as President and CEO and a Director of the Company, effective immediately.

Mr. Rosinski has a 25-year experience in oil and other petroleum product refining and oil and petroleum distribution. With his vast experience in the industry he is able to better direct the Company in its new direction, and rolling out the Company’s business strategy.

Ernest B. Remo remains a member of the Board of Directors as Chairman.

Patten Energy Solutions Group has also completed filing on OTC Markets its year-end Issuer Disclosure Statement and Financials for the fiscal year ended 2014 and the first three Quarters for fiscal year 2015. It is then the intention of the Company to complete a year end Disclosure Statement and Financial Information in a timely manner.

With the appointment of a new President and CEO the Company is actively seeking a new Corporate Headquarters. Further details will be announced as soon as possible.

Revenue

The company has recorded year to date revenue of $4,267,222 dollars through September 30 2015, up from 383,688 dollars from the period of December 31, 2014.

ABOUT PATTEN ENERGY SOLUTIONS GROUP, INC.

Patten Energy Solutions Group, Inc. formerly known as Integrated Energy Solutions Inc., a publicly traded Company on OTC Markets Exchange under the symbol (IENG), is a fully integrated large and small format downstream oil marketer, as well as waste oil collector, value-adding recycler and re-distributor. Through its subsidiary, Patten Energy Enterprises Inc., the company seeks to expand the regional businesses of each to other states where respective Company subsidiaries operate to vertically integrate, cost-share and generate new revenues from within the existing Company “ecosystem.”

FORWARD LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact:

Patten Energy Group Solutions, Inc.
Robert Rosinski, President /CEO
(312) 884-7626
email: rob@atl-pac.com

SOURCE: Patten Energy Group Solutions, Inc.

ReleaseID: 438242

Cameco Commences Drilling at CanAlaska’s West McArthur Project

VANCOUVER, BC / ACCESSWIRE / March 29, 2016 / CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N) (“CanAlaska” or the “Company”) is pleased to announce that the first drill program has commenced on the West McArthur project (“Project”) under the option agreement with Cameco Corporation (TSX: CCO) (NYSE MKT: CCJ) (“Cameco”). The agreement enables Cameco to earn up to a 60% interest in the Project through total expenditures of $12.5 million consisting of cash payments to the Company and accelerating exploration programs, culminating in a joint venture.

West McArthur Project Grid 5 Fox Lake Zone

To view an enhanced version of this image, please visit:
https://www.accesswire.com/uploads/19849_enhanced.jpg

The drill program will test new uranium exploration targets on the Grid 5 target, which is believed to host the western continuation of the C10 conductor horizon being explored by Cameco nearby at Fox Lake. The drilling will commence in the vicinity of historic drill hole EL-007 which was drilled in 1989. This hole is located on CanAlaska’s West McArthur property near the northern flexure of the main Grid 5 conductor and shows strongly silicified and altered rock in the top 400 metres of the sandstone column. This alteration zone appears to be cut off by a fault, which may correlate with the structure controlling the Fox Lake high-grade uranium mineral trend.

CanAlaska president Peter Dasler comments, “We are very pleased with the immediate attention that Cameco has given our project. The previous work carried out at Grid 5 indicates there has been a significant amount of mineralized fluid flow above the unconformity. The experience of the Cameco geological team with their model of high-grade mineralization related to major conductors and cross faults in this area, has already produced one significant zone of high-grade uranium mineralization at Fox Lake. We are all hopeful that extending exploration from the Read Lake property onto the West McArthur property will find additional uranium and a much larger discovery.”

The West McArthur Uranium Project covers 35,830 hectares (88,536 acres) commencing 6 kilometres (4 miles) northwest of Cameco’s majority owned McArthur River uranium mine. Importantly, the Project is immediately adjacent to Cameco’s recently disclosed Fox Lake uranium discovery with reported inferred resources of approximately 68.1 million pounds based on 387,000 tonnes at 7.99% U3O8. The Fox lake discovery is within the Read Lake project operated by Cameco (Cameco 78.2%, Areva 21.8%).

In other news, the Fond Du Lac project has been returned to the Community as it was near the end of its Federal lease term, and CanAlaska has a focused commitment to its key projects at West McArthur and Cree East. The Company strongly appreciates the support received from the Fond Du Lac Community over the life of the project, and fully anticipates that further work will be carried out on the key target identified by CanAlaska’s drill programs. CanAlaska is concentrating on pursuing further property option and joint venture opportunities under confidentiality agreements on its non-core projects. Recently the Company has received interest in its kimberlite exploration targets in the Western Athabasca.

Stay informed of Company and industry developments by subscribing to our email list:http://www.canalaska.com/s/RequestInformation.asp.

The qualified technical person for this news release is Dr Karl Schimann, P. Geo., CanAlaska director, and Vice President, Exploration.

About CanAlaska Uranium

CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N) holds interests in approximately 700,000 hectares (1.7 million acres), one of the largest land positions in Canada’s Athabasca Basin region – the “Saudi Arabia of Uranium.” CanAlaska’s strategic holdings has attracted major international mining companies Cameco, KORES and KEPCO as partners at its core projects. CanAlaska is a project generator and is positioned for discovery success in the world’s richest uranium district. For further information, visit www.canalaska.com.

About Cameco Corporation

Further information on Cameco can be found at www.cameco.com.

On behalf of the Board of Directors

“Peter Dasler”
Peter Dasler, M.Sc., P.Geo., President & CEO, CanAlaska Uranium Ltd.

Contact:

Peter Dasler, President and CEO
Tel: +1.604.688.3211 x 138
Email: info@canalaska.com

The TSX-V has not reviewed and does not accept responsibility for the adequacy or accuracy of this release: CUSIP# 13708P 10 2.

SOURCE: CanAlaska Uranium Ltd.

ReleaseID: 438240

.COM BATTLES – It Doesn’t Pay to Be Nice in Business Board Game is Officially Launched

The New Board Game is the First of its Kind for Entrepreneurs

LOS ANGELES, CA / ACCESSWIRE / March 29, 2016 / Game developer Vinson Pike is pleased to announce the launch of his unique board game, .COM BATTLES – It Doesn’t Pay to Be Nice in Business.

As Pike noted, .COM BATTLES is the first and only board game designed expressly for entrepreneurs. Describing it as entertaining and unique, Pike said the game is for anyone over 12 who is a budding entrepreneur, business owner, or wannabe.

Unlike other games that come with a pre-constructed board, players use hexagon-shaped pieces to build the board as they go. In doing so, Pike explained, players create a web of routes to take.

As for the basic goal of .COM BATTLES, Pike said it’s all about buying from and selling to others in an attempt to make the best deals and become the market leader.

“But to succeed, players will have to sabotage the business reputation of other players by destroying their feedback, obliterating their sales and making it difficult for them to keep their business afloat,” Pike said, adding that while doing this, players must further their own internet empire without their rivals robbing them of their success.

To win the game, Pike said players will need to have earned a heap of cash, gained and retained a minimum of five-stars and used all their hexagon board-pieces before returning to the center of the game to accomplish their goal of being internet entrepreneur of the year.

In order to help pay for the costs associated with creating .COM BATTLES, Vinson Pike has launched a fundraising campaign on Kickstarter. Ultimately, he hopes to raise $52,572 through crowdfunding.

As Pike explained, the production avenues of his new game and the manufacturers have already been chosen. Because of the diverse nature of .COM BATTLES, he is using a number of different suppliers and printers to complete the manufacturing process.

“We are continuing to tweak .COM BATTLES all the way through and beyond our Kickstarter campaign,” Pike said.

“Our plan is to start shipping the game within a few months of the crowd-funding ending, this allows some extra time for enhancement, design upgrades, and further ideas to be considered”

To learn more about .COM BATTLES or to make a donation, please visit https://goo.gl/kDZgKt.

About .COM BATTLES – It Doesn’t Pay to Be Nice in Business:

.COM BATTLES is the first and only board game for entrepreneurs. Developed by Vinson Pike, the game offers an entertaining look at what it is like to be a business owner.

Contact:

Ed Hale
admin@rocketfactor.com
(949) 555-2861

SOURCE: .COM BATTLES

ReleaseID: 438239